Amicus Therapeutics, Inc.
FOLD News Today: Stay Updated with the Latest Amicus Therapeutics, Inc. News in Real Time
Find FOLD news now at Meyka AI. Stay informed with the latest Amicus Therapeutics, Inc. stocks updates, including price news, market analysis, and expert insights.
April 05: RBA Cuts Hit Card Rewards; Qantas Points Without Credit Cards
RBA interchange fee cuts and a ban on surcharging will shrink credit card rewards Australia. See who wins, what to watch, and how to earn qantas points without credit c.
Pre-market: VisionSys AI 0T8B.F XETRA -37.50% on 04 Apr 2026: watch liquidity
Pre-market update on 0T8B.F stock: price €0.05, -37.50%, thin volume. Meyka AI forecast €1.81 quarterly, model-based projection.
BRMI.TO Boat Rocker Media (TSX) at C$8.90 on heavy volume: assess upside
BRMI.TO stock at C$8.90 on heavy volume; quick analysis, Meyka grade, and model forecasts for TSX-listed Boat Rocker Media
April 04: Queen-Harry Call Claims Lift UK Media, Book Demand Watch
Queen Elizabeth refused Prince Harry call claims boost UK media and royal book sales. We outline investor impacts, legal risks, and key signals to watch today.
TLFX Telefix (PNK) volume spike 89,773 shares 04 Apr 2026: watch liquidity
TLFX stock spikes on 89,773-volume trade 04 Apr 2026; TLFX stock analysis and Meyka AI forecast
5070.T DRAFT Inc. JPX JPY 746 intraday 04 Apr 2026: Oversold bounce probable
Intraday oversold bounce analysis for 5070.T stock at JPY 746 with targets, Meyka grade and short-term trade plan
Volume spike lifts QPTFF Quest PharmaTech (PNK) $0.03 Apr 04 2026: follow-up
QPTFF stock sees a volume surge to 225,625 shares on Apr 04 2026; short-term momentum and risks outlined
YRI.TO Yamana Gold Inc. TSX C$7.89 on 03 Apr 2026: volume spike signals active trading
Live market wrap on YRI.TO stock at C$7.89 with heavy volume and Meyka AI forecast
ITRM Iterum Therapeutics plc NASDAQ Q4 2025 results 03 Apr 2026: Earnings drivers and outlook
ITRM stock closed at $0.03 on 03 Apr 2026 after Q4 2025 results. Read Meyka AI earnings spotlight and short-term outlook for ITRM stock